Loading the company…
Loading the company…
㈜케이앤씨디어트레이드
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2007. Industry: Bio & Pharma. Revenue for 2025 was ₩11.3bn. It has 13 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2019-02-21 · latest registration 2019-05-10 · newest first
본 발명은 녹용의 전체 부위와 더불어 팁을 포함하는 분골을 최상의 상태로 가공하여 품질을 향상시키기 위한 가공 방법에 관한 것으로, 클린룸에서 냉동상태의 녹용을 해동시키는 과정, 복수의 건조 및 담금 과정을 수행하고, 워터쿠킹룸에서 고온수로 복수의 살균 과정을 수행하며, 오븐룸에서 숙성 과정을 수행함으로써, 녹용에 함유된 혈이 뭉치지 않고 원활한 순환이 이루어지도록 하고, 유효한 성분이 가장 많이 함유된 녹용의 팁 부위를 비롯하여 각 부위마다 확연한 구분과 더불어 각 부위마다 유효한 성분이 현저하게 드러날 수 있도록 하여 녹용의 생산성 및 품질을 고양시킨 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 12.4 | 11.3 |
| Cost of sales | 10.5 | 10.4 |
| Gross profit (loss) | 1.8 | 0.9 |
| Selling, general and administrative expenses | 1.2 | 1.2 |
| Operating income (loss) | (0.6) | 0.2 |
| Non-operating income | 0.1 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.1 | 0.1 |
| Non-operating expenses | 0.5 | 0.3 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.3 | 0.3 |
| Other | 0.2 | 0.0 |
| Profit (loss) before tax | (0.2) | 0.5 |
| Income tax expense | 0.0 | 0.0 |
| Net income (loss) | (0.1) | 0.5 |
Revenue ₩11.3bn, down 8.7% YoY.
Operating margin 2.0% (prior -4.8%).
Net income ₩0.5bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.